| TRRT.RTTR.TTRR.RRTT {replicateBE} | R Documentation |
Reference Dataset for TRRT|RTTR|TTRR|RRTT Designs
Description
Dataset from the public domain to be evaluated by method.A() and/or method.B().
Format
Reference Dataset 24
40 subjects (one completely missing).
Unbalanced (nine subjects in sequence TRRT and ten in each of the other three) and complete. Two outliers (subject 3 in sequence RTTR and subject 30 in sequence TTRR).
A data frame with 160 observations on the following 5 variables:- rds24
-
subjecta factor with 40 levels: 1, 2, ..., 932 perioda factor with 4 levels: 1, 2, 3, 4 sequencea factor with 4 levels: TRRT, RTTR, TTRR, RRTT treatmenta factor with 2 levels: T, R PKa numeric vector of pharmacokinetic responses acceptable for reference-scaling (here Cmax)
Details
| Dataset | N | CVwR (%) | Evaluation |
rds24 | 39 | >30 | method.A(), method.B()
|
Note
In software sequences and treatments are ranked in lexical order. Hence, executing str() or summary() will show sequence as "RRTT", "RTTR", "TRRT", "TTRR" and treatment as "R", "T". In BE – by convention – sequences are ordered with T first. The package follows this convention.
Source
| Dataset | Origin | Description |
rds24 | FDA, CDER | Cmax data of Drug 1. |
References
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Bioequivalence Studies. Rockville, 1997. bioequivalence study files (archived 2017-07-23)
Examples
str(rds24)
row <- c(13:16, 9:12, 1:4, 5:8)
rds24[row, ]
summary(rds24[2:5])